Nutex Health (NUTX)
(Delayed Data from NSDQ)
$0.75 USD
+0.01 (0.76%)
Updated May 24, 2024 04:00 PM ET
After-Market: $0.71 -0.04 (-4.77%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.75 USD
+0.01 (0.76%)
Updated May 24, 2024 04:00 PM ET
After-Market: $0.71 -0.04 (-4.77%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -100% and 3.21%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Nutex Health Inc. (NUTX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Nutex Health Inc. (NUTX) delivered earnings and revenue surprises of 0% and 5.34%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Enhabit (EHAB) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Enhabit (EHAB) delivered earnings and revenue surprises of -71.43% and 3.38%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Agiliti (AGTI) Q2 Earnings Lag Estimates
by Zacks Equity Research
Agiliti (AGTI) delivered earnings and revenue surprises of -6.67% and 2.41%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Pediatrix Medical Group (MD) Meets Q2 Earnings Estimates
by Zacks Equity Research
Pediatrix Medical Group (MD) delivered earnings and revenue surprises of 0% and 1.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Nutex Health Inc. (NUTX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Nutex Health Inc. (NUTX) delivered earnings and revenue surprises of 50% and 1.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?